Skip to content

Intraosseous Access

Comparison of NIO, BIG, EZ-IO, Jamshidi and Cook Intraosseous Devices in Adult Patients Under Resuscitation by Paramedics: a Randomized Crossover Manikin Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02275520
Acronym
NIO
Enrollment
137
Registered
2014-10-27
Start date
2014-12-31
Completion date
2015-05-31
Last updated
2015-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraosseus Access, Manikin, Resuscitation

Brief summary

The investigators will compare the success rates and time to successful IO access during simulated adult resuscitation.

Interventions

DEVICENIO Adult device

IO access-1

DEVICEBone Iniection Gun

IO access-2

DEVICEEZ-IO

IO access-3

DEVICEJamshidi Intraosseous Needle

IO access-4

DEVICECook Intraosseous Needle

IO access-5

Sponsors

International Institute of Rescue Research and Education
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Give voluntary consent to participate in the study * paramedic * more than 1 year experience in medicine

Exclusion criteria

* Not meet the above criteria * Wrist or Low back diseases

Design outcomes

Primary

MeasureTime frameDescription
time to IO needle insertion1 daytime from picking up a intraosseous access device, to successful IO needle insertion in the bone

Secondary

MeasureTime frameDescription
time to IO needle stabilization1 daytime from picking up a intraosseus access device to correct fixation IO needle
time to intraosseuss infusion1 daybegining with picking up a intraosseuss access device and ending with the IV line tubing was connected to the inseted IO needle
Ease of use1 dayTo access subjective opinion about the difficulty of the procedure, participants were asked to rate it on a visual analogue scale (VAS) with a score from 1 (extremely easy) to 10 (extremely difficult).

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026